Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Cancer Research|July 3, 2008
Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor betaShuang Wei, Andrew B Shreiner, Nobuhiro Takeshita, et al.Oncology Nursing Forum|February 25, 2016
Assessment of Cognitive Impairment and Complaints in Individuals With Colorectal CancerMoira A Visovatti, Patricia A Reuter-Lorenz, Alfred E Chang, et al.Nature Communications|October 28, 2020
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1sTakaaki Oba, Mark D Long, Tibor Keler, et al.Annals of Surgical Oncology|April 4, 2015
Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and OlderMichael S Sabel, David Kozminski, Kent Griffith, et al.Surgery|November 6, 2007
Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cellsMichael S Sabel, Alisha Arora, Gang Su, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|December 5, 2019
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapyFumito Ito, Trupti D Vardam, Michelle M Appenheimer, et al.World Journal of Oncology|June 23, 2023
Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor TherapyJoy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, et al.Head & Neck|February 25, 2003
Generation of vaccine-primed lymphocytes for the treatment of head and neck cancerAlfred E Chang, Qiao Li, Guihua Jiang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancerAlfred E Chang, Qiao Li, Guihua Jiang, et al.Journal for Immunotherapy of Cancer|January 25, 2025
Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapyRyutaro Kajihara, Mark D Long, Toshifumi Hoki, et al.Pageof 18